Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03081572 · ClinicalTrials.gov registry record
Platelet Function on Abacavir and Tenofovir
A clinical trial of Cardiovascular Diseases and HIV/AIDS, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT03081572 is a study of Cardiovascular Diseases and HIV/AIDS that has completed, run by University of California, Los Angeles. The registered enrollment target is 24 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03081572, a study of Cardiovascular Diseases and HIV/AIDS, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a small observational study aimed at observing differences in platelet function in HIV patients on abacavir versus tenofovir based anti-HIV drugs. There is some correlation between platelet activation and cardiovascular disease- this study will act as a pilot to see if platelet activation among abacavir users may explain the correlation between abacavir and cardiovascular disease in HIV positive patients. This study will enroll 44 participants total; 22 on abacavir-based treatment, 22 on tenofovir-based treatment. There is only one study visit which includes a blood draw, physical assessment, and review of medical history.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Platelet aggregation
Study Locations (1)
California
- Clinical AIDS Research and Education Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2020-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03081572
The ClinicalTrials.gov registry entry for NCT03081572 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Platelet aggregation is the first listed.
NCT03081572 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03081572 about?
NCT03081572 is a clinical study titled "Platelet Function on Abacavir and Tenofovir". This is a small observational study aimed at observing differences in platelet function in HIV patients on abacavir versus tenofovir based anti-HIV drugs. There is some correlation between platelet activation and cardiovascular disease- this study will act as a pilot to see if platelet activation am...
What is the current status of trial NCT03081572?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2018-04-30. Estimated completion is 2020-02-15.
What conditions does trial NCT03081572 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, HIV/AIDS, Platelet Aggregation, Spontaneous.
What interventions are being tested in trial NCT03081572?
The interventions under investigation include: Platelet aggregation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03081572?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03081572 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.